Vaccines as Potential Frontliners Against Antimicrobial Resistance (AMR): A Focused Review

Area of Science:

• Microbiology
• Immunology
• Public Health

Background:

• Antimicrobial resistance (AMR) is a critical global health threat, diminishing antibiotic effectiveness and increasing infectious disease treatment complexity.
• Vaccines are being explored as a key strategy to mitigate AMR by preventing bacterial infections and consequently reducing antibiotic usage.
• Targeting multidrug-resistant bacteria like *M. tuberculosis*, *E. coli*, and *S. aureus* with vaccines can decrease infection spread and healthcare costs.

Purpose of the Study:

• To review the crucial role of vaccines in addressing the global challenge of antimicrobial resistance.
• To highlight the potential of vaccines in preventing infections caused by drug-resistant bacteria.
• To discuss the challenges hindering vaccine development and accessibility for combating AMR.

Main Methods:

• This review synthesizes current research on vaccine development for antimicrobial resistance.
• It emphasizes the correlation between vaccine strategies and global AMR issues.
• Key challenges, including antigenic variability and economic barriers, are examined.

Main Results:

• Vaccines can significantly reduce antibiotic use, thereby limiting the emergence and spread of resistant pathogens.
• Development of vaccines against high-priority pathogens like ESKAPE is complex due to immune evasion and antigenic diversity.
• Economic and logistical barriers, especially in low- and middle-income countries, restrict vaccine accessibility.

Conclusions:

• Vaccine development and research are essential for preventing AMR and promoting judicious antibiotic use.
• Overcoming challenges in vaccine accessibility and efficacy is crucial for their successful deployment against superbugs.
• Strategic investment in vaccine research is a cornerstone for mitigating the global dissemination of resistant bacteria.